Columbus A/S
8.9.2025 09:40:46 CEST | Globenewswire | Press release
Columbus – Weekly report on share buyback
Columbus – Weekly report on share buyback
Company announcement no. 21/2025
Transactions in the period 1 September 2025 to 5 September 2025
On 30 June 2025, Columbus A/S announced a share buyback programme under which the company will repurchase shares for up to DKK 16m during the period from 30 June 2025 to 11 March 2026, both dates included, as outlined in company announcement no. 8/2025.
The share buyback programme is executed in accordance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations.
The following transactions were made under the share buyback programme in the period 1 September 2025 to 5 September 2025:
| Number of shares bought | Average purchase price (DKK) | Transaction value (DKK) | |
| Accumulated, last announcement | 565,749 | 10.08 | 5,703,518.75 |
| 1 September 2025 | 11,500 | 9.81 | 112,773.60 |
| 2 September 2025 | 4,444 | 9.85 | 43,778.73 |
| 3 September 2025 | 13,769 | 10.04 | 138,082.42 |
| 4 September 2025 | 7,085 | 10.05 | 71,204.25 |
| 5 September 2025 | 12,500 | 10.25 | 128,180.00 |
| Total, 1 September 2025 to 5 September 2025 | 49,298 | 10.02 | 494,019.00 |
| Total accumulated under the programme | 615,047 | 10.08 | 6,197,537.75 |
With the transactions stated above, Columbus A/S holds a total of 615,047 own shares, corresponding to 0.48% of the Company’s share capital.
Ib Kunøe Søren Krogh Knudsen
Chairman of the Board CEO & President
For further information, please contact: CEO & President, Søren Krogh Knudsen, +45 70 20 50 00 |
Attachments
- SE_21_2025_Weekly_report_on_share_buyback
- Columbus - Share buyback transactions 1 September 2025 - 5 September 2025
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
F. Hoffmann-La Roche Ltd25.10.2026 16:30:00 CET | Press release
Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer
Genmab A/S25.10.2026 12:00:00 CET | Press release
Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
Genmab A/S24.10.2026 13:00:00 CEST | Press release
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
ASYAD24.10.2026 12:47:36 CEST | Press release
Asyad Group to Host Muscat Maritime Resilience Forum to Strengthen Global Trade Networks
King Faisal Specialist Hospital & Research Centre24.10.2026 11:00:00 CEST | Press release
KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom